Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance

C. Sarrecchia, V. Svicher, A. Volpi, R. Salpini, L. Ceccarelli, P. Sordillo, A. Bertoli, C. F. Perno, M. Andreoni

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA

Original languageEnglish
Pages (from-to)367-370
Number of pages4
JournalInfection
Volume39
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Tenofovir
Chronic Hepatitis B
Immunocompromised Host
Hepatitis B virus
Viremia
Drug Resistance
Mutation
DNA
Serum
entecavir

Keywords

  • Drug resistance
  • Entecavir
  • Hepatitis B
  • Immunocompromised
  • Therapy

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. / Sarrecchia, C.; Svicher, V.; Volpi, A.; Salpini, R.; Ceccarelli, L.; Sordillo, P.; Bertoli, A.; Perno, C. F.; Andreoni, M.

In: Infection, Vol. 39, No. 4, 08.2011, p. 367-370.

Research output: Contribution to journalArticle

Sarrecchia, C. ; Svicher, V. ; Volpi, A. ; Salpini, R. ; Ceccarelli, L. ; Sordillo, P. ; Bertoli, A. ; Perno, C. F. ; Andreoni, M. / Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. In: Infection. 2011 ; Vol. 39, No. 4. pp. 367-370.
@article{05397ae4a1b242dd957205d20e184f32,
title = "Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance",
abstract = "We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA",
keywords = "Drug resistance, Entecavir, Hepatitis B, Immunocompromised, Therapy",
author = "C. Sarrecchia and V. Svicher and A. Volpi and R. Salpini and L. Ceccarelli and P. Sordillo and A. Bertoli and Perno, {C. F.} and M. Andreoni",
year = "2011",
month = "8",
doi = "10.1007/s15010-011-0127-3",
language = "English",
volume = "39",
pages = "367--370",
journal = "Infection",
issn = "0300-8126",
publisher = "Urban und Vogel GmbH",
number = "4",

}

TY - JOUR

T1 - Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance

AU - Sarrecchia, C.

AU - Svicher, V.

AU - Volpi, A.

AU - Salpini, R.

AU - Ceccarelli, L.

AU - Sordillo, P.

AU - Bertoli, A.

AU - Perno, C. F.

AU - Andreoni, M.

PY - 2011/8

Y1 - 2011/8

N2 - We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA

AB - We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA

KW - Drug resistance

KW - Entecavir

KW - Hepatitis B

KW - Immunocompromised

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=80655144427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80655144427&partnerID=8YFLogxK

U2 - 10.1007/s15010-011-0127-3

DO - 10.1007/s15010-011-0127-3

M3 - Article

VL - 39

SP - 367

EP - 370

JO - Infection

JF - Infection

SN - 0300-8126

IS - 4

ER -